1 / 57

ALLERGY IN ALABAMA

ALLERGY IN ALABAMA. SPRING - FLOWERING GRASSES, ORNAMENTAL FLOWERS, NOT PINE POLLEN FALL – RAGWEED NOT GOLDENROD YEAR ROUND-ANIMAL DANDER AND SALIVA SUMMER/HUMIDITY -MOLDS/ FUNGUS. RAGWEED GOLDENROD. Welcome to Alabama. Timothy Grass. Bermuda Grass. HYPERSENSITIVITY REACTIONS.

zihna
Télécharger la présentation

ALLERGY IN ALABAMA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ALLERGY IN ALABAMA • SPRING - FLOWERING GRASSES, ORNAMENTAL FLOWERS, NOT PINE POLLEN • FALL – RAGWEED NOT GOLDENROD • YEAR ROUND-ANIMALDANDER AND SALIVA • SUMMER/HUMIDITY -MOLDS/ FUNGUS

  2. RAGWEED GOLDENROD

  3. Welcome to Alabama

  4. Timothy Grass

  5. Bermuda Grass

  6. HYPERSENSITIVITY REACTIONS • TYPE I- ALLERGIC CONJUNCTIVITIS • TYPE II- MYASTHENIA GRAVIS • TYPE III-UVEITIS? SJOGRENS • TYPE IV- CONTACT DERMATITIS & GPC

  7. Allergic conjunctivitis

  8. Myasthenia Gravis

  9. Sjogrens

  10. Phlyctenular Conjunctivitis

  11. ALLERGY CASCADE • IGE BINDS ANTIGEN • FORMS DIMER AT SURFACE OF MAST CELL • MAST CELL DEGRANULATES HISTAMINE PROSTAGLANDINS THROMBOXANES LEUKOTRIENES VASOACTIVE AMINES EOSINOPHIL ATTRACTING FACTOR

  12. STAGES OF ALLERGIC DISEASE • EARLY PHASE • MAST CELLS AND PRODUCTS • LATE PHASE • LEUKOCYTES • T -LYMPHOCYTES • CHRONIC PHASE • T CELLS FACTORS

  13. MAST CELLS • DIFFERENT TYPES OF MAST CELLS • CHYMASE POSITIVE • TYPTASE POSITIVE (all mast cells, most common ocular surface, prevents clotting) • CHYMASE AND TYPTASE (most common in non allergic)

  14. calcium

  15. Inside Mast Cells • Increase synthesis of phosopholipase A-production of arachodonic acid • Increase protein kinase production-necessary for degranulation • Increase in intracellular calcium levels • 24-48 hours increase cytokine production

  16. CGMP • INCREASES MAST CELL DEGRANULATION • ALPHA AGONISTS INCREASE • BY DECREASING CAMP • CHOLINERGICS INCREASE CGMP

  17. CAMP • DECREASES DEGRANULATION • HISTAMINE INCREASES • BETA ADRENERGIC DRUGS INCREASE • ADENYL CYCLASE(PROSTAGLANDINS)

  18. cAMP cGMP Balance CAMP CGMP

  19. PROSTAGLANDIN D2 • PRIMARY OCULAR PG IN HYPERSENSITIVITY • CHEMOSIS • REDNESS • DISCHARGE • EOSINOPHIL CHEMOTAXIS

  20. BIOLOGIC ACTIVITY OF PROSTAGLANDINS • PGF2 & PGD2- BRONCHOSPASM • PGI2- PULMONARY DILATION & < PLATELET AGGREGATION • PGE2 BRONCHODILATOR • PGE1 &PGE2 -> NERVE SENSITIVITY VASODILATION • TXA2-VASOCONSTRICTION

  21. BIOLOGIC ACTIVITY OF LEUKOTRIENES • LTB4 • PMN ATTRACTANT • EOSINOPHIL ATTRACTANT • > VASCULAR PERMEABILITY • >.EDEMA • COFACTOR W/ PGE2 & PGD2 • LTC4, LTD4, LTE4 • BRONCHOCONSTRICTORS • MYOCARDIAL DEPRESSANTS

  22. EOSINOPHILS-ACTIVATION • EOSINOPHIL CHEMOTACTIC FACTOR(LTB4) • HISTAMINASE DECREASES • PHOSPHOLIPASE DECREASES • ARYL SULFATASE DECREASES • PLATELET ACTIVATING FACTOR STRONGLYATTRACTS

  23. EOSINOPHILS • MAJOR BASIC PROTEIN (anti-parasite) • HIGHLY TOXIC TO EPITHELIUM • INCREASES MAST CELL DEGRANULATION • EOSINOPHIL CATIONIC PROTEIN • EOSINOPHIL PEROXIDASE

  24. HISTAMINE • BRONCHOSPASM • VASODILATOR • INCREASES VASCULAR PERMEABILITY • ACTIVATES NERVE TERMINALS

  25. PLATELET ACTIVATING FACTOR RELEASING CELLS • BASOPHILS • MAST CELLS • EOSINOPHILS • MONOCYTES/MACROPHAGES • PMN’S

  26. T CELL MEDIATED FACTORS • IL-3 INDUCES MAST CELL DEGRANULATION • IL-4 FACILITATES IGE PRODUCTION BY B LYMPHOCYTES • IL-5 STIMULATES EOSINOPHIL PROLIFERATION

  27. OCULAR RESPONSE IN ARACHADONIC ACID PATHWAY • CYCLO-OXYGENASE PATHWAY • LID SWELLING • CHEMOSIS • VASODILATION • LIPO-OXYGENASE PATHWAY • CHRONIC INFLAMMATION

  28. OCULAR SURFACE HISTAMINE RECEPTORS • H1 RECEPTORS- NEURONAL • PRODUCES ITCHING • H2 RECEPTORS- VASCULAR • PRODUCES REDNESS

  29. DIAGNOSIS OF ALLERGY • RAST (RADIOALLERGOSORBANT ASSAY) • PRICK TESTS • INDERATION TESTS • DIRECT CHALLENGE • CONJUNCTIVAL CHALLENGE

  30. CONJUNCTIVAL CHALLENGE • FDA REQUIREMENT FOR NEW DRUGS • ALLERGEN APPLIED TO CONJ • REDNESS,WATERING,CHEMOSIS GRADED • RETEST WITH PRETREATMENT

  31. DRUG ACTIONS • MAST CELL STABILIZERS • STEROIDS • ANTIHISTAMINES • ASPIRIN • NONSTEROIDALS • VASOCONSTRICTORS • THEOPHYLLINE

  32. STEROID ACTIONS • DECREASE mRNA • INHIBITS PHOSPHOLIPASE A • POTENTIATES B ADRENERGICS • CONSTRICTS BLOOD VESSELS • DECREASES CHEMOTAXIS • LYMPHOPENIA • DECREASES MACROPHAGE FUNCTION • GI, RENAL, PLATELET, MACROPHAGE DIFFERENTIATION

  33. STEROID EFFECTS • DECREASE MESSENGER RNA • INHIBITS PHOSPHOLIPASE A PRODUCTION • INCREASES CAMP • POTENTIATES B ADRENERGIC DRUGS • CONSTRICTS BLOOD VESSELS • DECREASES CHEMOTAXIS • LYMPHOPENIA • DECREASED MACROPHAGE FUNCTION

  34. DRUG ACTIONS • STEROIDS-MULIPLE EFFECTS • MAST CELL STABILIZERS-INHIBIT CALCIUM ENTRY INTO CELL • ANTIHISTIMINES- EFFECT AFTER RELEASE • ASPIRIN - INHIBITS CYCLO-OXYGENASE PATHWAY • NONSTEROIDALS- INHIBIT CYCLO-OXYGENASE PATHWAY

  35. COX 1 AND COX 2 • COX 1 PRESENT AT STEADY STATE LEVELS • HOMEOSTATIC FUNCTIONS • COX 2 ASSOCIATED WITH INFLAMMATION • VIOXX, CELEBREX, BEXTRA • PREFERENTIAL VS SPECIFIC

  36. DRUG EFFECTS • VASOCONSTRICTORS -REVERSE VASODILATION • THEOPHYLLINE- INCREASE CAMP

  37. FOOD ALLERGY • VARIABLE EFFECT DUE TO ABSORBTION • USUALLY LOCAL GI EFFECT • CAN BE IDIOSYNCRATIC

  38. ALLERGIC SKIN REACTIONS • ERYTHEMA-REDNESS • FLARE-DIFFUSE REDNESS AROUND WHEAL • WHEAL-LOCALIZED EDEMA,TYPICAL LID • ANGIOEDEMA

  39. DRUG ALLERGY • TOXICITY • INTOLERANCE • IDIOSYNCRATIC • ALLERGIC

More Related